CVS vs TNYA · P/E 16, rev $106.10B vs rev $1.3M
CVS Health Corp (CVS) versus Tenaya Therapeutics Inc (TNYA) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Tenaya Therapeutics Inc (TNYA) is a biotechnology company listed on NASDAQ.
Latest reported CVS revenue for 2026-06-30 was $106.10B. Net income was $2.98B. Revenue was up 5.6% from 2026-03-31 to 2026-06-30. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported TNYA revenue for 2026-06-30 was $1.3M. Net income was -$62.7M. TNYA currently screens at market cap $156.0M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. TNYA currently screens at market cap $156.0M.
Not investment advice. Open the CVS and TNYA stock pages for the full models.
Not investment advice.